Order Article Reprints

Khattulanuar FS, Sekar M, Fuloria S, Gan SH, Rani NNIM, Ravi S, Chidambaram K, Begum MY, Azad AK, Jeyabalan S, et al. Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders. Molecules. 2022; 27(3):673. https://doi.org/10.3390/molecules27030673

Khattulanuar, Farrah Syazana, Mahendran Sekar, Shivkanya Fuloria, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Subban Ravi, Kumarappan Chidambaram, M. Yasmin Begum, Abul Kalam Azad, Srikanth Jeyabalan, and et al. 2022. "Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders" Molecules 27, no. 3: 673. https://doi.org/10.3390/molecules27030673

Khattulanuar, F. S., Sekar, M., Fuloria, S., Gan, S. H., Rani, N. N. I. M., Ravi, S., Chidambaram, K., Begum, M. Y., Azad, A. K., Jeyabalan, S., Dhiravidamani, A., Thangavelu, L., Lum, P. T., Subramaniyan, V., Wu, Y. S., Sathasivam, K. V., & Fuloria, N. K. (2022). Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders. Molecules, 27(3), 673. https://doi.org/10.3390/molecules27030673